样式: 排序: IF: - GO 导出 标记为已读
-
Endometriosis is Associated with Higher Healthcare Utilization and Upper Gastrointestinal Symptoms Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-19 Madison Simons PsyD, Michael Cline MD, Ashley Gubbels MD, Cara King MD, Anthony Lembo MD, Stephen Lupe PsyD
-
Algorithm Training and Testing for a Non-Endoscopic Barrett’s Esophagus Detection Test in Prospective Multicenter Cohorts Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-19 Prasad G. Iyer MD MSc, Seth W. Slettedahl MS, Douglas W. Mahoney MS, Maria Giakoumopoulos PhD, Marilyn C. Olson PhD, Martin Krockenberger PhD, William R. Taylor MS, Patrick Foote BS, Calise Berger BS, Cadman Leggett MD, T.T. Wu MD PhD, Eduardo Antpack MD, Gary W. Falk MD MS, Gregory G. Ginsberg MD, Julian A. Abrams MD, Charles J. Lightdale MD, Francisco Ramirez MD, Allon Kahn MD, Herbert Wolfsen MD
-
Severe Fatigue in Inflammatory Bowel Disease: Dopaminergic Therapy with Modanfinil or Vitamin Therapy with Thiamine Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-19 Palle Bager, Christian L. Hvas, Jens Frederik Dahlerup
-
Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-15 Jean-Frédéric Colombel, Tadakazu Hisamatsu, Raja Atreya, Francesca Bresso, Lena Thin, Remo Panaccione, Rogério Serafim Parra, Sharanya Ford, Valencia P. Remple, Ana Paula Lacerda, Samuel I. Anyanwu, Madhuja Mallick, Andrew Garrison, Miguel Regueiro
-
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-15 Laurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, Raja Atreya, David T. Rubin, James O. Lindsay, Jesse Siffledeen, Dana J. Lukin, John Wright, Kenji Watanabe, Sharanya Ford, Valencia P. Remple, Ana P. Lacerda, Elena Dubcenco, Andrew Garrison, Qian Zhou, Sofie Berg, Samuel I. Anyanwu, Stefan Schreiber
-
Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in-utero Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-15 Ralley Prentice, Emma Flanagan, Emily K. Wright, Peter R. Gibson, Sam Rosella, Ourania Rosella, Jakob Begun, Yoon-Kyo An, Ian C. Lawrance, Michael A. Kamm, Miles Sparrow, Rimma Goldberg, Lani Prideaux, Sara Vogrin, Katerina V. Kiburg, Alyson L. Ross, Megan Burns, Sally J. Bell
-
Esophageal Enigma: Isolated Lower Esophageal Sphincter Amyloidosis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Alam Merchant M.D, Raul S. Gonzalez M.D, Anand Jain M.D
-
Validation of the THCC-RI predictive model for hepatocellular carcinoma in Asian cohort Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Jeong-Ju Yoo, Young-Gi Song, Ji Eun Moon, Young Seok Kim, Sang Gyune Kim
-
Risk of Cancer in Patients with Diverticular Disease: A Population-based Cohort Study Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Frederikke S. Troelsen, Dóra K. Farkas, Rune Erichsen, Lisa L. Strate, John A. Baron, Henrik T. Sørensen
Several studies have investigated the association between diverticular disease (DD) and colorectal cancer. However, whether there is an association between DD and malignancies other than those in the colorectum remains uncertain. For the 1978-2019 period, we conducted a nationwide, population-based cohort study using national Danish healthcare data. We followed DD patients for up to 20 years, beginning
-
Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-10 Amrit K. Kamboj, Dhyanesh A. Patel, Rena Yadlapati
-
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-04 Stephen A. Harrison, Juan P. Frias, K. Jean Lucas, Gary Reiss, Guy Neff, Sureka Bollepalli, Yan Su, Doreen Chan, Erik J. Tillman, Ali Moulton, Brittany de Temple, Arian Zari, Reshma Shringarpure, Timothy Rolph, Andrew Cheng, Kitty Yale
-
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-02 Duco T. Mülder, Anne I. Hahn, Robert J. Huang, Margaret J. Zhou, Benjamin Blake, Omonefe Omofuma, John D. Murphy, Daniela S. Gutiérrez-Torres, Ann G. Zauber, James F. O’Mahony, M. Constanza Camargo, Uri Ladabaum, Jennifer M. Yeh, Chin Hur, Iris Lansdorp-Vogelaar, Reinier Meester, Monika Laszkowska
-
The Efficacy of Real-Time Computer-Aided Detection of Colonic Neoplasia In Community Practice: A Pragmatic Randomized Controlled Trial. Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-02 Nikhil R. Thiruvengadam MD, Pejman Solaimani MD, Manish Shrestha MD, Seth Buller, Rachel Carson PA, Breanna Reyes-Garcia PA, Ronaldo D. Gnass MD, Bing Wang MD PhD, Natalie Albasha BS, Paul Leonor MD, Monica Saumoy MD MS, Raul Coimbra MD, Arnold Tabuenca MD, Wichit Srikureja MD, Steve Serrao MD MPH PhD
The use of computer-aided detection (CADe) has increased the adenoma detection rates (ADR) during colorectal cancer (CRC) screening/surveillance in randomized controlled trials (RCT) but has not shown benefit in real-world implementation studies. We performed a single-center pragmatic RCT to evaluate the impact of real-time CADe on ADR in colonoscopy performed by community gastroenterologists. We enrolled
-
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Pojsakorn Danpanichkul, Cheng Han Ng, Darren Jun Hao Tan, Karn Wijarnpreecha, Daniel Q. Huang, Mazen Noureddin, Young Alcohol Disease Collaborative, Benjamin Nah, Jia Hong Koh, Margaret Teng, Wen Hui Lim, Vijay Ramadoss, Elizabeth Thong, Mark Muthiah, Zhen Yu Wong, Apichat Kaewdech, Kwanjit Duangsonk, Ken Liu, Tomoya Sano, Hirokazu Takahashi, Vincent Chen, Brian P. Lee
-
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Anouk M. Wijnands, Bas B.L. Penning de Vries, Maurice W.M.D. Lutgens, Zeinab Bakhshi, Ibrahim Al Bakir, Laurent Beaugerie, Charles N. Bernstein, Ryan Chang-ho Choi, Nayantara Coelho-Prabhu, Trevor A. Graham, Ailsa L. Hart, Joren R. ten Hove, Steven H. Itzkowitz, Julien Kirchgesner, Erik Mooiweer, Seth R. Shaffer, Shailja C. Shah, Sjoerd G. Elias, Bas Oldenburg, Dutch Initiative on Crohn and Colitis
-
Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Madeleine Chang, Devon Chang, Sudha Kodali, Stephen A. Harrison, Mark Ghobrial, Naim Alkhouri, Mazen Noureddin
-
The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-29 Jordan E. Axelrad MD MPH, David T. Rubin MD
-
Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Jasmohan S. Bajaj, Nikolaos T. Pyrsopoulos, Robert S. Rahimi, Zeev Heimanson, Christopher Allen, Don C. Rockey
-
Phosphatidylethanol Detects Occult Heavy Alcohol Use in Patients With Acute and Chronic Pancreatitis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Nicole Wong, Cihang Gu, Dhiraj Yadav, Gregory A. Cote, Oregon Pitt Pancreatology Working Group, Emily Jonica, Saad Jazrawi, Melissa Saul, Kaveh Sharzehi, Jessica Yu
-
White Paper AGA: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States–Removing Barriers and Embracing Opportunities Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 M. Anthony Sofia, Joseph D. Feuerstein, Leslie Narramore, Karen A. Chachu, Sarah Streett
Despite incredible growth in systems of care and rapidly expanding therapeutic options for people with inflammatory bowel disease, there are significant barriers that prevent patients from benefiting from these advances. These barriers include restrictions in the form of prior authorization, step therapy, and prescription drug coverage. Furthermore, inadequate use of multidisciplinary care and inflammatory
-
Emotional Intelligence: An Impactful Yet Often Overlooked Skill That Can Enhance Physician Well-being and Professional Satisfaction Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 David J. Hass, Marc A. Brackett
-
Antibiotic Exposure and Risk of New-Onset Inflammatory Bowel Disease: A Systematic Review and Dose-Response Meta-Analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Ruqiao Duan, Cunzheng Zhang, Gaonan Li, Jun Li, Liping Duan
-
Global Prevalence of Pancreatic Cystic Lesions in the General Population on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Ana Vilela, Elit Quingalahua, Alejandra Vargas, Fadi Hawa, Carol Shannon, Eileen S. Carpenter, Jiaqi Shi, Somashekar G. Krishna, Un-Jung Lee, Jean M. Chalhoub, Jorge D. Machicado
-
Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-28 Neeraj Narula, Emily C.L. Wong, Parambir S. Dulai, Jaiminkumar Patel, John K. Marshall, Clara Yzet, Vipul Jairath, Ryan Ungaro, Jean-Frederic Colombel, Walter Reinisch, the CALM LTE investigators
-
MALT Lymphoma of the Esophagus Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-27 Jingjing Lian, Aiping Xu, Meidong Xu
-
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-27 Vivek C. Goodoory, Mais Khasawneh, Christopher J. Black, Alexander C. Ford
The gold standard symptom-based criteria for diagnosis of irritable bowel syndrome (IBS) are the Rome IV criteria. These are more restrictive than their predecessor, Rome III, because the cardinal feature required to meet criteria for IBS was changed to presence of abdominal pain alone, rather than abdominal pain or discomfort. This change was made because discomfort was believed to be an ambiguous
-
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized Patients Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-23 Michael Li, Danny Wong, Jordan S. Sack, Alexander S. Vogel, F. Stephen Hodi, Lawrence Fong, Jennifer C. Lai, Stephen D. Zucker, Shilpa Grover
-
AGA Clinical Practice Update on High-Quality Upper Endoscopy: Expert Review Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-22 Satish Nagula, Sravanthi Parasa, Loren Laine, Shailja C. Shah
-
-
-
Approaching Digestive Health Care in Transgender and Gender-Diverse Communities Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-21 Christopher Vélez, Kira L. Newman, Sonali Paul, Jens U. Berli, Vin Tangpricha, Laura E. Targownik
-
-
-
-
-
DNA Methylation Profiling Enables Accurate Classification of Nonductal Primary Pancreatic Neoplasms Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-20 Anna Vera D. Verschuur, Wenzel M. Hackeng, Florine Westerbeke, Jamal K. Benhamida, Olca Basturk, Pier Selenica, G. Mihaela Raicu, I. Quintus Molenaar, Hjalmar C. van Santvoort, Lois A. Daamen, David S. Klimstra, Shinichi Yachida, Claudio Luchini, Aatur D. Singhi, Christoph Geisenberger, Lodewijk A.A. Brosens
-
Global Epidemiology of Gallstones in the 21st Century: A Systematic Review and Meta-Analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-19 Xin Wang, Wenqian Yu, Guoheng Jiang, Hongyu Li, Shiyi Li, Linjun Xie, Xuan Bai, Ping Cui, Qi Chen, Yanmei Lou, Li Zou, Sulian Li, Zhongfang Zhou, Chi Zhang, Peng Sun, Min Mao
Gallstones are common and associated with substantial health and economic burden. We aimed to comprehensively evaluate the prevalence and incidence of gallstones in the 21st century. We systematically searched PubMed and Embase to identify studies reporting the prevalence and/or incidence of gallstones between January 1, 2000, and November 18, 2023. Pooled prevalence and incidence were calculated using
-
Biliary Neuroendocrine Tumor Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-17 Neil Khoury, Qian Wu, Murali Dharan
-
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-17 Erica J. Brenner, Kimberly N. Weaver, Xian Zhang, Arthur J. Kastl, Jennifer A. Strople, Jeremy Adler, Marla C. Dubinsky, Athos Bousvaros, Runa Watkins, Xiangfeng Dai, Wenli Chen, Raymond K. Cross, Peter D.R. Higgins, Ryan C. Ungaro, Meenakshi Bewtra, Emanuelle A. Bellaguarda, Francis A. Farraye, Kelly Y. Chun, Michael Zikry, Monique Bastidas, Ann Firestine, Riley G. Craig, Margie E. Boccieri, Millie
-
Dysphagia and Regurgitated Mass Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-16 Maunoo Lee, Saha Sadeghi, Ronald A. Mathiasen
-
Heartburn Relief Is the Major Unmet Need for Drug Development in Gastroesophageal Reflux Disease: Threshold Value Analysis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-16 Eric D. Shah, Michael A. Curley, Amit Patel, Wai-Kit Lo, Walter W. Chan
-
Association Between Celiac Disease and Irritable Bowel Syndrome: A Nationwide Cohort Study Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-16 Karl Mårild, Jonas Söderling, Benjamin Lebwohl, Peter H.R. Green, Hans Törnblom, Magnus Simrén, Kyle Staller, Ola Olén, Jonas F. Ludvigsson
-
Sex Differences and Immunoglobulin E Should Not Be Forgotten in Type 1 Autoimmune Pancreatitis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 Wen-Feng Xi, Xiao-Yin Bai, Ai-Ming Yang
-
Choosing a Comparator: Minimizing Baseline Differences Between Groups Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 Mary A. Andrews, Shirin M. Hemmat, Tram T. Tran
-
Reply Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 June Tome, Sahil Khanna, Darrell S. Pardi
-
Prescribing of Proton Pump Inhibitors for Prevention of Upper Gastrointestinal Bleeding in US Outpatient Visits Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 Jacob E. Kurlander, John N. Mafi, Michael J. Racz, Geoffrey D. Barnes, Sameer D. Saini, Patrick D. Meek, Gastrointestinal Bleeding Working Group, Elliot B. Tapper, Jeffrey T. Kullgren, Joel H. Rubenstein, Caroline R. Richardson, Danielle Helminski
-
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 Layla A. Abushamat, Pir Ahmad Shah, Robert H. Eckel, Stephen A. Harrison, Diana Barb
-
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 Mei-Hsuan Lee, Yi-Ting Chen, Yu-Han Huang, Sheng-Nan Lu, Tsai-Hsuan Yang, Jee-Fu Huang, Szu-Ching Yin, Ming-Lun Yeh, Chung-Feng Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Hwai-I Yang, Hsuan-Yu Chen, Chien-Jen Chen
The impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on the development of cirrhosis and hepatocellular carcinoma (HCC) by chronic hepatitis B (CHB) or C infection and antiviral treatment statuses is not well-known. A total of 336,866 adults aged ≥30 years were prospectively enrolled in a health screening program between 1997–2013. MASLD was identified by abdominal ultrasonography
-
Multilevel Interventions to Improve Colorectal Cancer Screening in an Urban Native American Community: A Pilot Randomized Clinical Trial Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 Aasma Shaukat, Jack Wolf, Kyle Ryder, Jennifer P. Wisdom, Timothy R. Church
-
Assessment and Significance of Histologic Activity in Crohn’s Disease Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-15 Alexandros D. Polydorides
-
Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-13 Junya Arai, Atsushi Miyawaki, Tomonori Aoki, Ryota Niikura, Yoku Hayakawa, Hiroaki Fujiwara, Sozaburo Ihara, Mitsuhiro Fujishiro, Masato Kasuga
Potassium-competitive acid blockers (PCABs) have been increasingly used to treat upper gastrointestinal disorders, replacing proton pump inhibitors (PPIs). Whereas PPIs are associated with an increased risk of gastric cancer (GC) after eradication, it is uncertain whether PCABs carry the same risk. Using a population-based claims database in Japan, we identified patients who were prescribed a clarithromycin-based
-
Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-13 Linhua Zheng, Siyuan Tian, Chunmei Yang, Bo Li, Gui Jia, Yansheng Liu, Ruiqing Sun, Xiufang Wang, Juan Deng, Miao Zhang, Lina Cui, Changcun Guo, Xinmin Zhou, Patrick S.C. Leung, Christopher L. Bowlus, M. Eric Gershwin, Yulong Shang, Ying Han
-
Dissecting Geographical and Racial Disparities in H. pylori Infection Rates: Screening and Eradication Strategies in the U.S. Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-10 Yasutoshi Shiratori MD MPH PhD, Naoki Ishii MD MPH PhD, Anthony Kalloo MD
-
Glucagon-Like Peptide-1 Receptor Agonists in Patients With Cirrhosis: Answering the Unanswered Questions? Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-10 Sara Mahgoub, Philip N. Newsome MD PhD
-
Reply Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-10 Markos Kalligeros MD, Eleftherios Mylonakis MD PhD, Mazen Noureddin MD
-
From ChatGPT to GutGPT: Enhancing AI for Personalized Health Care Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-10 Qingzhou Kong MD, Yueyue Li MD PhD, Yanqing Li MD PhD
-
Feasibility and Colonoscopy Yield Using the Fecal Immunochemical Test (FIT)-Based Colorectal Cancer Screening in a Latin America Country Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-09 Mauricio Paulin Sorbello, Ulysses Ribeiro Júnior, José Eluf-Neto, Vinicius Pfuetzenreiter, Afonso Henrique da Silva e Sousa Júnior, Fábio Shiguehissa Kawaguti, Diane Dede Cohen, Evandro Sobroza de Mello, Sergio Carlos Nahas, Adriana Vaz Safatle-Ribeiro
Organized colorectal cancer (CRC) screening is not widely practiced in Latin America and the results of regional studies may help overcome barriers for implementation of national screening programs. We aimed to describe the implementation and findings of a fecal immunochemical test (FIT)-based program in Brazil. In a prospective population-based study, asymptomatic individuals (50–75 years old) from
-
Pathogenic Variant Intraductal Papillary Mucinous Neoplasms Tumors Show Increased Tumor Growth Compared With Those With Familial Pancreatic Cancer Kindreds: Prognostic Indicators Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-06 Mitchell S. Cappell, Martin Tobi
Abstract not available
-
Gastric Malignancies in United States in the Period From 2000 to 2018 Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-06 H, e, l, g, e, , L, ., , W, a, l, d, u, m
Abstract not available
-
Reply Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-02-05 Shang-Chin Huang, Tung-Hung Su, Jia-Horng Kao
Abstract not available